2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | |
Weighted Average Number Of Diluted Shares Outstanding | 143.66 | 143.39 | 141.36 | NA | 137.03 | 134.83 | 132.17 | |
Weighted Average Number Of Shares Outstanding Basic | 143.66 | 143.39 | 141.36 | NA | 137.03 | 134.83 | 132.17 | |
Earnings Per Share Basic | -0.58 | -0.52 | -0.56 | -0.54 | -0.57 | -0.53 | -0.25 | |
Earnings Per Share Diluted | -0.58 | -0.52 | -0.56 | -0.54 | -0.57 | -0.53 | -0.25 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 0.05 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 | 38.34 | |
Revenues | 0.05 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 | 38.34 | |
Operating Expenses | 82.54 | 76.68 | 80.05 | 73.94 | 77.72 | 71.07 | 71.55 | |
Research And Development Expense | 63.64 | 57.17 | 60.16 | 53.98 | 58.72 | 52.29 | 55.18 | |
General And Administrative Expense | 18.90 | 19.51 | 19.90 | 19.96 | 19.00 | 18.78 | 16.36 | |
Operating Income Loss | -82.49 | -76.59 | -79.99 | -73.89 | -77.67 | -71.03 | -33.20 | |
Allocated Share Based Compensation Expense | 21.15 | 22.89 | 22.32 | 22.04 | 20.86 | 21.13 | 16.79 | |
Profit Loss | -83.15 | -74.79 | -79.85 | -74.87 | -78.19 | -70.94 | -33.02 | |
Net Income Loss | -83.15 | -74.79 | -79.85 | -74.87 | -78.19 | -70.94 | -33.02 | |
Comprehensive Income Net Of Tax | -84.63 | -77.01 | -86.53 | -77.04 | -78.25 | -71.17 | -33.38 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Assets | 887.57 | 947.64 | 964.63 | 1038.63 | 1079.25 | 1126.72 | 1179.04 | |
Liabilities | 147.61 | 145.69 | 109.40 | 122.23 | 109.30 | 102.91 | 109.27 | |
Liabilities And Stockholders Equity | 887.57 | 947.64 | 964.63 | 1038.63 | 1079.25 | 1126.72 | 1179.04 | |
Stockholders Equity | 739.96 | 801.95 | 855.23 | 916.41 | 969.94 | 1023.81 | 1069.78 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Assets Current | 569.06 | 513.03 | 469.74 | 471.32 | 502.86 | 602.17 | 716.06 | |
Cash And Cash Equivalents At Carrying Value | 74.36 | 96.04 | 84.51 | 173.31 | 190.02 | 223.50 | 236.87 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 84.65 | 106.33 | 94.81 | 183.61 | 199.47 | 232.95 | 246.31 | |
Prepaid Expense And Other Assets Current | 16.83 | 22.54 | 20.69 | 14.02 | 19.37 | 14.46 | 16.48 | |
Available For Sale Securities Debt Securities | 582.21 | NA | NA | 752.03 | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 149.03 | 147.94 | 147.25 | 146.35 | 145.00 | 142.25 | 137.97 | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 34.59 | 30.73 | 27.05 | 23.36 | 19.12 | 16.79 | 14.82 | |
Property Plant And Equipment Net | 114.44 | 117.22 | 120.20 | 122.99 | 125.88 | 125.46 | 123.15 | |
Investments In Affiliates Subsidiaries Associates And Joint Ventures | 14.05 | 15.70 | 14.20 | 18.00 | 17.91 | 18.82 | 19.35 | |
Other Assets Noncurrent | 9.38 | 8.94 | 9.04 | 5.82 | 6.16 | 5.83 | 6.28 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Liabilities Current | 48.87 | 44.91 | 36.88 | 48.17 | 53.49 | 46.00 | 54.85 | |
Accounts Payable Current | 11.04 | 9.71 | 8.71 | 10.26 | 11.50 | 11.01 | 14.88 | |
Contract With Customer Liability Current | 0.89 | 0.84 | 0.41 | 0.42 | 0.36 | 0.30 | 0.24 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Other Liabilities Noncurrent | 2.03 | 2.55 | 3.49 | 4.12 | 5.17 | 5.71 | 2.79 | |
Operating Lease Liability Noncurrent | 96.71 | 98.23 | 69.03 | 69.93 | 50.64 | 51.21 | 51.62 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Stockholders Equity | 739.96 | 801.95 | 855.23 | 916.41 | 969.94 | 1023.81 | 1069.78 | |
Common Stock Value | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | |
Additional Paid In Capital Common Stock | 1893.91 | 1871.26 | 1847.53 | 1822.18 | 1798.68 | 1774.30 | 1749.10 | |
Retained Earnings Accumulated Deficit | -1141.13 | -1057.98 | -983.20 | -903.35 | -828.48 | -750.29 | -679.36 | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -12.96 | -11.47 | -9.25 | -2.57 | -0.40 | -0.33 | -0.10 | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 21.15 | 22.89 | 22.32 | 22.04 | 20.86 | 21.13 | 16.79 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -47.66 | -42.53 | -68.24 | -45.44 | -48.88 | -41.17 | -49.33 | |
Net Cash Provided By Used In Investing Activities | 24.91 | 54.03 | -22.38 | 29.25 | 13.01 | 24.59 | 96.80 | |
Net Cash Provided By Used In Financing Activities | 1.07 | 0.02 | 1.81 | 0.32 | 2.38 | 3.21 | 6.04 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -47.66 | -42.53 | -68.24 | -45.44 | -48.88 | -41.17 | -49.33 | |
Net Income Loss | -83.15 | -74.79 | -79.85 | -74.87 | -78.19 | -70.94 | -33.02 | |
Profit Loss | -83.15 | -74.79 | -79.85 | -74.87 | -78.19 | -70.94 | -33.02 | |
Increase Decrease In Accounts Payable | 1.01 | 1.42 | -0.51 | -2.04 | 0.19 | -3.06 | 4.15 | |
Share Based Compensation | 21.15 | 22.89 | 22.32 | 22.04 | 20.86 | 21.13 | 16.79 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | 24.91 | 54.03 | -22.38 | 29.25 | 13.01 | 24.59 | 96.80 | |
Payments To Acquire Property Plant And Equipment | 0.22 | 1.37 | 1.90 | 0.74 | 3.35 | 10.90 | 6.46 | |
Payments To Acquire Investments | 49.45 | 61.71 | 89.16 | 50.78 | 145.42 | 180.33 | 149.05 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 1.07 | 0.02 | 1.81 | 0.32 | 2.38 | 3.21 | 6.04 |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 0.05 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 | 38.34 | |
Allogene Overland Allogene Overland Bio Pharm H K Limited | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 38.30 | |
Revenue From Contract With Customer Excluding Assessed Tax | 0.05 | 0.09 | 0.06 | 0.05 | 0.05 | 0.04 | 38.34 | |
Allogene Overland Allogene Overland Bio Pharm H K Limited | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 38.30 |